Studies on the syntheses on N heterocyclic compounds. XXVIII. Syntheses of pyrido[3,4 d]pyridazine derivatives (4)

DOI: 10.1248/cpb.24.2699

Source and publish data:

Chemical and Pharmaceutical Bulletin p. 2699 - 2710 (1976)

Update date:2022-08-05

Topics:

Authors:

Omura Omura

Tada Tada

Tomimoto

et al. et al.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1248/cpb.24.2699

Full text of DOI:10.1248/cpb.24.2699

NII-Electronic Library Service

Products guided by the article

Product name:1H-Pyrrolo[3,4-c]pyridine-1,3(2H)-dione, 7-amino-6-phenyl-

Cas No:62437-11-0

R&D Labs maybe for 62437-11-0

New Forms

Contact:+31-24-3886056

Address:Binderskampweg 29 Unit 36
Shanghai Sungo Technology Chemical Co., Ltd

Contact:0086-21-51385579

Address:Room2010, F/20, Tonghua Plaza, NO 345 Jinxiang Road, Jinqiao Export Processing Zone, Shanghai, 201206 P.R.CHINA
Neworld Chemical Co., Ltd Shanghai(expird)

Contact:+86-21-62202658

Address:11F, Blvd 2, No. 1969 PuXing Rd, Shanghai
QUZHOU ZIO I/E CO.;LTD

Contact:13357117572

Address:No.149 Shiji dadao Road.
Shijiazhuang Frontierchem Co., Ltd.

Contact:+86-311-89271196

Address:4-4-202 No.15 Biandian Street,Shijiazhuang

Relevant to this article

Concise synthesis of semicarbazides and formylhydrazines via direct addition reaction between aromatic azoarenes and N-substituted formamides

Doi:10.1039/c4ra17015f
(2015)
Design, synthesis, and insecticidal activities of phthalamides containing a hydrazone substructure

Doi:10.1021/jf1000919
(2010)
A novel approach towards the synthesis of tricyclic systems based on pyridine, pyran, thiopyran, azepine, oxepin, thiepin, and pyrimidine rings under different solvent conditions

Doi:10.1139/V10-015
(2010)
Novel synthesis of heterocycle-annulated azocine derivatives of biological relevance by aromatic aza-claisen rearrangement and intramolecular heck reaction

Doi:10.1055/s-0029-1218630
(2010)
Polymer Nanoparticles Modified with Photo- and pH-Dual-Responsive Polypeptides for Enhanced and Targeted Cancer Therapy

Doi:10.1021/acs.molpharmaceut.5b00977
(2016)
Pharmacokinetics-Driven Optimization of 4(3 H)-Pyrimidinones as Phosphodiesterase Type 5 Inhibitors Leading to TPN171, a Clinical Candidate for the Treatment of Pulmonary Arterial Hypertension

Doi:10.1021/acs.jmedchem.9b00123
(2019)

Article Doi